6533b7d6fe1ef96bd12670fe

RESEARCH PRODUCT

Effect of EDTA and citrate on the functional activity of the first component of complement, C1, and the C1q subcomponent.

S. ZapfMichael Loos

subject

Chemical PhenomenaComplement Activating EnzymesMacromolecular SubstancesImmunologyKineticschemistry.chemical_elementCalciumHemolysisDissociation (chemistry)Structure-Activity RelationshipComplement C1medicineImmunology and AllergyStructure–activity relationshipHumansChelationCitratesComplement C1qEdetic AcidComplement C1qHematologymedicine.diseaseHemolysisChemistryKineticsBiochemistrychemistryEdetic AcidCalcium

description

The first component of complement, C1, is a calcium-dependent complex of the three distinct subcomponents, C1q, C1r, and C1s. Earlier observations revealed that treatment of C1 with EDTA led to a loss of hemolytic C1 activity even after recalcification. Therefore, it was of interest to study whether EDTA has an additional effect on C1 and its subcomponents, beside its chelating capacity. The chelating effect of EDTA was compared to that of citrate. It was found that treatment of C1 or C1 with EDTA followed by addition of Ca++ led to a loss of hemolytic activity up to 90%, depending on EDTA concentration. Even pretreatment of EDTA with varying amounts of Ca++ did not prevent the inactivation of C1 or C1. In contrast, after dissociation of C1 or C1 by citrate, 100% of the original C1q activity is recoverable on addition of C1q deficient serum as source of C1r and C1s. EDTA-treated serum, however, showed a concentration-dependent loss of hemolytic C1q activity, indicating an inhibitory effect of EDTA on C1q. EDTA-treated C1q, fluid phase or bound to EA, was no longer able to form an hemolytically active C1 complex by interaction with C1r and C1s.

10.1016/s0171-2985(85)80085-1https://pubmed.ncbi.nlm.nih.gov/3932188